TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an update.
China Isotope & Radiation Corporation (CIRC) has signed a Memorandum of Understanding with Brazil’s National Commission for Nuclear Energy to establish a long-term cooperation mechanism. This partnership aims to enhance isotope product supply, quality management, and information exchange, supporting Brazil’s nuclear technology and radiopharmaceutical industries. The agreement is expected to help CIRC expand its international cooperation, promote its technologies, and contribute to the peaceful uses of nuclear technology.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) is a leading Chinese company specializing in isotopes and radiopharmaceuticals. The company focuses on the development and supply of isotope products and services, with a market emphasis on nuclear technology applications and public health.
Average Trading Volume: 297,498
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.13B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.